vs

Side-by-side financial comparison of BayCom Corp (BCML) and GERON CORP (GERN). Click either name above to swap in a different company.

GERON CORP is the larger business by last-quarter revenue ($47.2M vs $25.9M, roughly 1.8× BayCom Corp). BayCom Corp runs the higher net margin — 26.5% vs -39.0%, a 65.5% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 9.4%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 2.9%).

BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

BCML vs GERN — Head-to-Head

Bigger by revenue
GERN
GERN
1.8× larger
GERN
$47.2M
$25.9M
BCML
Growing faster (revenue YoY)
GERN
GERN
+57.6% gap
GERN
67.1%
9.4%
BCML
Higher net margin
BCML
BCML
65.5% more per $
BCML
26.5%
-39.0%
GERN
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
2.9%
BCML

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
BCML
BCML
GERN
GERN
Revenue
$25.9M
$47.2M
Net Profit
$6.9M
$-18.4M
Gross Margin
Operating Margin
36.6%
-29.4%
Net Margin
26.5%
-39.0%
Revenue YoY
9.4%
67.1%
Net Profit YoY
12.1%
30.3%
EPS (diluted)
$0.63
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCML
BCML
GERN
GERN
Q4 25
$25.9M
Q3 25
$25.7M
$47.2M
Q2 25
$24.7M
$49.0M
Q1 25
$24.3M
$39.6M
Q4 24
$23.7M
Q3 24
$25.6M
$28.3M
Q2 24
$23.8M
$882.0K
Q1 24
$24.5M
$304.0K
Net Profit
BCML
BCML
GERN
GERN
Q4 25
$6.9M
Q3 25
$5.0M
$-18.4M
Q2 25
$6.4M
$-16.4M
Q1 25
$5.7M
$-19.8M
Q4 24
$6.1M
Q3 24
$6.0M
$-26.4M
Q2 24
$5.6M
$-67.4M
Q1 24
$5.9M
$-55.4M
Operating Margin
BCML
BCML
GERN
GERN
Q4 25
36.6%
Q3 25
26.3%
-29.4%
Q2 25
35.3%
-25.4%
Q1 25
31.6%
-42.2%
Q4 24
34.2%
Q3 24
32.4%
-99.8%
Q2 24
31.9%
-7860.9%
Q1 24
33.3%
-18465.1%
Net Margin
BCML
BCML
GERN
GERN
Q4 25
26.5%
Q3 25
19.5%
-39.0%
Q2 25
25.8%
-33.4%
Q1 25
23.4%
-50.1%
Q4 24
25.9%
Q3 24
23.5%
-93.5%
Q2 24
23.6%
-7639.8%
Q1 24
24.0%
-18220.4%
EPS (diluted)
BCML
BCML
GERN
GERN
Q4 25
$0.63
Q3 25
$0.46
$-0.03
Q2 25
$0.58
$-0.02
Q1 25
$0.51
$-0.03
Q4 24
$0.55
Q3 24
$0.54
$-0.04
Q2 24
$0.50
$-0.10
Q1 24
$0.51
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCML
BCML
GERN
GERN
Cash + ST InvestmentsLiquidity on hand
$78.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$338.6M
$248.7M
Total Assets
$2.6B
$567.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCML
BCML
GERN
GERN
Q4 25
Q3 25
$78.1M
Q2 25
$77.7M
Q1 25
$83.7M
Q4 24
Q3 24
$60.3M
Q2 24
$116.9M
Q1 24
$189.8M
Stockholders' Equity
BCML
BCML
GERN
GERN
Q4 25
$338.6M
Q3 25
$334.3M
$248.7M
Q2 25
$330.6M
$259.5M
Q1 25
$329.3M
$268.2M
Q4 24
$324.4M
Q3 24
$321.7M
$292.3M
Q2 24
$315.3M
$306.7M
Q1 24
$314.2M
$344.9M
Total Assets
BCML
BCML
GERN
GERN
Q4 25
$2.6B
Q3 25
$2.6B
$567.4M
Q2 25
$2.6B
$555.2M
Q1 25
$2.6B
$562.5M
Q4 24
$2.7B
Q3 24
$2.6B
$444.9M
Q2 24
$2.6B
$449.4M
Q1 24
$2.6B
$482.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCML
BCML
GERN
GERN
Operating Cash FlowLast quarter
$31.8M
$-13.6M
Free Cash FlowOCF − Capex
$30.1M
FCF MarginFCF / Revenue
116.2%
Capex IntensityCapex / Revenue
6.7%
Cash ConversionOCF / Net Profit
4.64×
TTM Free Cash FlowTrailing 4 quarters
$51.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCML
BCML
GERN
GERN
Q4 25
$31.8M
Q3 25
$7.3M
$-13.6M
Q2 25
$6.4M
$-27.4M
Q1 25
$9.3M
$-48.0M
Q4 24
$30.4M
Q3 24
$9.6M
$-58.9M
Q2 24
$7.7M
$-53.5M
Q1 24
$5.1M
$-62.3M
Free Cash Flow
BCML
BCML
GERN
GERN
Q4 25
$30.1M
Q3 25
$6.2M
Q2 25
$5.6M
Q1 25
$9.1M
Q4 24
$28.7M
Q3 24
$9.4M
Q2 24
$7.4M
$-53.7M
Q1 24
$3.9M
$-62.9M
FCF Margin
BCML
BCML
GERN
GERN
Q4 25
116.2%
Q3 25
24.3%
Q2 25
22.8%
Q1 25
37.6%
Q4 24
121.1%
Q3 24
36.6%
Q2 24
31.2%
-6086.6%
Q1 24
16.1%
-20680.3%
Capex Intensity
BCML
BCML
GERN
GERN
Q4 25
6.7%
Q3 25
4.3%
Q2 25
3.0%
Q1 25
0.6%
Q4 24
7.2%
Q3 24
1.0%
0.0%
Q2 24
1.0%
23.4%
Q1 24
4.7%
202.3%
Cash Conversion
BCML
BCML
GERN
GERN
Q4 25
4.64×
Q3 25
1.47×
Q2 25
1.00×
Q1 25
1.63×
Q4 24
4.96×
Q3 24
1.60×
Q2 24
1.37×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons